EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Financial Indicator Details
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ ROHTO PHARMACEUTICAL +
@ エスケー化研 +
@ ダイセル +
@ Dainippon Sumitomo Pharma +
@ アステラス製薬 +
@ Takeda Pharmaceutical +
@ Fuso Pharmaceutical Industries +
@ ONO PHARMACEUTICAL +
@ Mitsubishi Tanabe Pharma +
@ ADEKA +
@ キッセイ薬品工業 +
@ Nissan Chemical Industries +
@ キョーリン製薬ホールディングス +
@ Kuraray +
@ 持田製薬 +
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-03 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
Hitachi Zosen etc.
graph
NIPPON COKE & ENGINEERING
graph
Nissan Motor
graph
クラリオン
graph
クラリオン
graph

Financial Indicator Details: 持田製薬 (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

*Free Download Financial Indicator data

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability2009-03-312010-03-312011-03-312012-03-312013-03-31
Net profit margin
(Industry Average)
11.64%
(-12.05%)
12.56%
(-0.50%)
6.70%
(1.53%)
10.52%
(-1.67%)
10.25%
(3.05%)
C/F margin
(Industry Average)
14.10%
(-3.31%)
15.55%
(8.51%)
8.88%
(7.04%)
10.09%
(6.35%)
13.34%
(8.25%)
ROA
(Industry Average)
8.55%
(0.52%)
9.23%
(1.04%)
4.91%
(2.07%)
8.04%
(0.06%)
7.57%
(2.71%)
ROE
(Industry Average)
11.80%
(-1.43%)
12.37%
(0.03%)
6.82%
(2.96%)
11.04%
(4.68%)
10.33%
(4.57%)
Growth2009-03-312010-03-312011-03-312012-03-312013-03-31
Equity growth
(Industry Average)
-
(-)
7.57%
(5.01%)
-2.05%
(2.61%)
5.19%
(-0.40%)
7.72%
(8.16%)
Sales growth
(Industry Average)
-
(-)
4.47%
(-2.67%)
1.21%
(5.36%)
8.42%
(1.07%)
3.48%
(2.24%)
Net profit growth
(Industry Average)
-
(-)
12.73%
(203.46%)
-45.96%
(63.25%)
70.18%
(3.89%)
0.83%
(90.38%)
Operating C/F growth
(Industry Average)
-
(-)
15.16%
(275.10%)
-42.20%
(35.09%)
23.29%
(-6.09%)
36.79%
(138.39%)
Stability2009-03-312010-03-312011-03-312012-03-312013-03-31
Capital adequacy
(Industry Average)
72.45%
(53.80%)
74.65%
(54.51%)
71.95%
(55.00%)
72.81%
(53.59%)
73.27%
(56.30%)
Liquidity ratio
(Industry Average)
317.72%
(217.72%)
350.65%
(225.70%)
334.17%
(237.55%)
332.62%
(239.89%)
341.92%
(236.21%)
C/F ratio current liabilities
(Industry Average)
202.10%
(777.21%)
172.30%
(303.31%)
327.13%
(434.79%)
274.19%
(929.73%)
212.89%
(573.30%)
Quick ratio
(Industry Average)
200.45%
(138.97%)
229.47%
(148.85%)
216.07%
(156.17%)
201.49%
(160.84%)
224.39%
(156.81%)
Turnover2009-03-312010-03-312011-03-312012-03-312013-03-31
Receivables turnover
(Industry Average)
115.00day
(83.89day)
109.99day
(94.27day)
116.48day
(93.96day)
109.28day
(97.92day)
113.67day
(98.27day)
Inventory turnover
(Industry Average)
60.54day
(54.45day)
54.23day
(52.58day)
48.97day
(52.64day)
56.60day
(56.59day)
58.85day
(58.68day)
Payable turnover
(Industry Average)
37.32day
(45.01day)
34.36day
(49.82day)
36.69day
(49.52day)
42.74day
(52.10day)
42.07day
(51.12day)
Working capita turnover
(Industry Average)
138.22day
(93.32day)
129.86day
(97.02day)
128.77day
(97.08day)
123.14day
(102.41day)
130.46day
(105.83day)
Stock etc.2009-03-312010-03-312011-03-312012-03-312013-03-31
Market Value growth
(Industry Average)
-
(-)
-8.62%
(34.57%)
8.10%
(1.49%)
-4.03%
(-3.85%)
20.82%
(21.16%)
Dividend Yield
(Industry Average)
2.05%
(3.20%)
2.34%
(1.93%)
2.29%
(2.17%)
2.00%
(2.45%)
2.06%
(2.07%)
PER
(Industry Average)
13.99%
(25.22%)
11.34%
(23.06%)
22.69%
(16.22%)
12.79%
(29.19%)
15.33%
(16.58%)
PBR
(Industry Average)
1.65%
(0.86%)
1.40%
(1.06%)
1.54%
(1.04%)
1.41%
(0.95%)
1.58%
(1.08%)
PCFR
(Industry Average)
11.55%
(7.18%)
9.16%
(9.23%)
17.14%
(-2.43%)
13.34%
(9.50%)
11.78%
(7.56%)
PSR
(Industry Average)
1.62%
(0.77%)
1.42%
(0.88%)
1.52%
(1.10%)
1.34%
(0.90%)
1.57%
(1.01%)

Financial Indicator Details: 持田製薬

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Profitability
Net profit margin11.64%12.56%6.70%10.52%10.25%
C/F margin14.10%15.55%8.88%10.09%13.34%
ROA8.55%9.23%4.91%8.04%7.57%
ROE11.80%12.37%6.82%11.04%10.33%
Recurring margin18.03%18.99%15.11%17.73%15.90%
EBIT margin18.14%20.06%10.26%17.59%15.77%
EBITDA margin21.71%23.66%13.86%20.99%18.98%
NOPAT margin10.88%12.03%6.15%10.55%9.46%
Sales SG rates37.89%37.04%38.20%34.61%36.76%
Sales SG&A rates44.81%45.19%47.09%48.05%47.54%
Sales R&D expenses rates-----
Sales depreciation rates3.56%3.60%3.60%3.40%3.20%
Capital expenditures net sales ratio-5.15%-2.42%-3.09%-1.74%-2.29%
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Growth
Growth rate of cash-27.72%-0.38%-9.16%30.59%
Equity growth-7.57%-2.05%5.19%7.72%
Total assets growth-4.39%1.62%3.95%7.04%
Sales growth-4.47%1.21%8.42%3.48%
Net profit growth-12.73%-45.96%70.18%0.83%
Operating C/F growth-15.16%-42.20%23.29%36.79%
Recurring profit growth-10.02%-19.46%27.20%-7.18%
EBIT growth-15.48%-48.21%85.84%-7.19%
EBITDA growth-13.82%-40.67%64.13%-6.42%
NOPAT growth-15.48%-48.21%85.84%-7.19%
Operating expenses growth-----
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Stability
Capital adequacy72.45%74.65%71.95%72.81%73.27%
Liquidity ratio317.72%350.65%334.17%332.62%341.92%
C/F ratio current liabilities202.10%172.30%327.13%274.19%212.89%
Quick ratio200.45%229.47%216.07%201.49%224.39%
Fixed ratio25.36%22.61%22.56%20.81%18.83%
D/E ratio1.48%0.62%2.55%1.06%0.98%
Loan to Value Ratio1.07%0.46%1.84%0.77%0.72%
Business investment C/F ratio-36.51%-15.56%-34.81%-17.32%-17.15%
Liabilities with interest growth--54.54%300.00%-56.25%-
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Turnover
Cash turnover93.63day114.46day112.65day94.37day119.09day
Receivables turnover115.00day109.99day116.48day109.28day113.67day
Inventory turnover60.54day54.23day48.97day56.60day58.85day
Fixed assets turnover91.29day83.80day80.93day72.43day68.23day
Total asset turnover496.87day496.48day498.46day477.90day494.36day
Payable turnover37.32day34.36day36.69day42.74day42.07day
Capital turnover35.09day33.59day33.18day30.60day29.57day
Equity turnover359.99day370.66day358.67day347.99day362.26day
Working capita turnover138.22day129.86day128.77day123.14day130.46day
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Balance sheet
Cash etc.¥ 19 B¥ 24 B¥ 24 B¥ 22 B¥ 29 B
Accounts receivable-trade¥ 23 B¥ 23 B¥ 25 B¥ 25 B¥ 27 B
Other Current Assets¥ 48 B¥ 49 B¥ 52 B¥ 57 B¥ 57 B
Current Assets¥ 68 B¥ 73 B¥ 77 B¥ 79 B¥ 86 B
Tangible Assets¥ 18 B¥ 18 B¥ 17 B¥ 17 B¥ 16 B
Intangible Assets¥ 1 B¥ 1 B¥ 1 B¥ 902 M¥ 621 M
Investment etc.¥ 14 B¥ 13 B¥ 12 B¥ 15 B¥ 16 B
Total Assets¥ 102 B¥ 106 B¥ 108 B¥ 112 B¥ 120 B
Current Liabilities¥ 21 B¥ 21 B¥ 23 B¥ 23 B¥ 25 B
Fixed Liabilities¥ 6 B¥ 6 B¥ 7 B¥ 6 B¥ 6 B
Liabilities with interest¥ 1 B¥ 500 M¥ 2 B¥ 875 M¥ 875 M
Net Assets¥ 74 B¥ 79 B¥ 78 B¥ 82 B¥ 88 B
Capital stock¥ 7 B¥ 7 B¥ 7 B¥ 7 B¥ 7 B
Capital surplus etc.¥ 66 B¥ 72 B¥ 70 B¥ 74 B¥ 81 B
Liabilities and net assets¥ 102 B¥ 106 B¥ 108 B¥ 112 B¥ 120 B
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Income statement
Sales¥ 75 B¥ 78 B¥ 79 B¥ 86 B¥ 89 B
Cost of Sales¥ 28 B¥ 29 B¥ 30 B¥ 29 B¥ 32 B
Gross profit¥ 46 B¥ 49 B¥ 49 B¥ 56 B¥ 56 B
Other income¥ 1 B¥ 2 B¥ 436 M¥ 1 B¥ 380 M
SG&A¥ 33 B¥ 35 B¥ 37 B¥ 41 B¥ 42 B
Other expenses¥ 5 B¥ 6 B¥ 6 B¥ 6 B¥ 5 B
Net income¥ 8 B¥ 9 B¥ 5 B¥ 9 B¥ 9 B
Operating income¥ 12 B¥ 13 B¥ 11 B¥ 14 B¥ 14 B
Ordinary Income¥ 13 B¥ 14 B¥ 12 B¥ 15 B¥ 14 B
EBITDA¥ 16 B¥ 18 B¥ 11 B¥ 18 B¥ 16 B
Income before income taxes¥ 13 B¥ 15 B¥ 8 B¥ 15 B¥ 14 B
Depreciation¥ 2 B¥ 2 B¥ 2 B¥ 2 B¥ 2 B
R&D expenses-----
Income taxes¥ 4 B¥ 5 B¥ 2 B¥ 6 B¥ 4 B
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Cash flow statement
Operating CF¥ 10 B¥ 12 B¥ 7 B¥ 8 B¥ 11 B
Investment CF¥ -3 B¥ -638 M¥ -1 B¥ -1 B¥ -1 B
Financial CF¥ -7 B¥ -5 B¥ -4 B¥ -6 B¥ -4 B
Foreign Exchange Effects-----
Net Change in Cash¥ -65 M¥ 6 B¥ 409 M¥ 1 B¥ 5 B
Free CF¥ 7 B¥ 11 B¥ 5 B¥ 7 B¥ 9 B
Capital expenditures¥ -3 B¥ -1 B¥ -2 B¥ -1 B¥ -2 B
Cash dividends paid¥ -2 B¥ -2 B¥ -2 B¥ -2 B¥ -2 B
Repayment loans¥ -600 M¥ -600 M-¥ -375 M¥ -375 M
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Shareowners' equity
Issuance of new shares-----
Dividends from surplus¥ -2 B¥ -2 B¥ -2 B¥ -2 B¥ -2 B
Net income¥ 8 B¥ 9 B¥ 5 B¥ 9 B¥ 9 B
Purchase of treasury stock¥ -4 B¥ -2 B¥ -3 B¥ -3 B¥ -975 M
Other Change in Stockholders Equity¥ -2 M-¥ 1 M-¥ 1 M
Other Change in Net Assets¥ -2 B¥ 632 M¥ -793 M¥ 962 M¥ 1 B
Net Change in Net Assets¥ 38 M¥ 5 B¥ -1 B¥ 4 B¥ 6 B

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link


Ticker Market Industry Month report Rating
@ 持田製薬 4534 TSE 1st Chemicals 3 Annual A

Related Company

@ ダイセル (Sales ¥ 358 B) +
@ Kuraray (Sales ¥ 369 B) +
@ Aica Kogyo (Sales ¥ 101 B) +
@ MANDOM (Sales ¥ 60 B) +
@ Dainippon Sumitomo Pharma (Sales ¥ 347 B) +
@ アステラス製薬 (Sales ¥ 1.0 T) +
@ 長谷川香料 (Sales ¥ 45 B) +
@ 富士製薬工業 (Sales ¥ 25 B) +
@ 千寿製薬 (Sales ¥ 28 B) +
@ TSUMURA & CO. (Sales ¥ 105 B) +
@ Sekisui Chemical (Sales ¥ 1.0 T) +
@ Toray Industries (Sales ¥ 1.5 T) +
@ キョーリン製薬ホールディングス (Sales ¥ 107 B) +

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (0.107 sec.)